Low-dose interleukin-2 (IL-2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Low-dose interleukin-2 (IL-2), covering 2020-01-13 to 2020-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection [Phase 1, Phase 2]